SCHEMBL30937579

SCHEMBL30937579

O=C(O)CN1Cc2nc(Cl)ccc2NC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ CYP2D6 P10635 3/20 0.35
▸ CYP2C19 P33261 3/20 0.35
▸ POLB P06746 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ XIAP P98170 1/20 0.34
▸ BIRC2 Q13490 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ KMO O15229 1/20 0.33
▸ ITGB1 P05556 1/20 0.33
▸ ITGAV P06756 1/20 0.33
▸ ALDH1A1 P00352 3/20 0.32
▸ MAPT P10636 2/20 0.32
▸ HTT P42858 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937727 0.83 ACE (0.35) ACEMMP13CYP2D6CYP2C19POLB
SCHEMBL30937745 0.80 TRPV1 (0.35) ACEMMP13CYP2D6CYP2C19POLB
SCHEMBL30937588 0.71 ACE (0.48) ACEMMP13CYP2D6CYP2C19POLB
SCHEMBL30937665 0.70 ACE (0.47) ACEMMP13CYP2D6CYP2C19POLB
SCHEMBL30937679 0.69 BRD4 (0.51) ACEMMP13CYP2D6CYP2C19POLB
SCHEMBL30937732 0.68 ACE (0.44) ACEMMP13CYP2D6CYP2C19POLB
SCHEMBL30937538 0.68 PER2 (0.45) CYP2D6CYP2C19CYP2C9KMT2ACYP1A2
SCHEMBL30937524 0.68 ACE (0.44) ACEMMP13CYP2D6CYP2C19POLB
SCHEMBL30937518 0.67 DPP4 (0.38) ACEMMP13CYP2D6CYP2C19CYP2C9
SCHEMBL8345781 0.66 TSHR (0.39) ACEMMP13CYP2D6CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback